Larvol Delta - Blade-Therapeutics-Updates-Enrollment-Progress-for-Phase-2-Study-of-Lead-Investigational-Therapy-BLD2660-in-Treating-Patients-with-COVID19-Pneumonia

BLD-2660 - Blade Therap

https://www.businesswire.com/news/home/20200812005362/en/Blade-Therapeutics-Updates-Enrollment-Progress-Phase-2

Aug 12, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next